Celularity (CELUW) Accumulated Expenses (2020 - 2025)
Celularity (CELUW) reported Accumulated Expenses of $32.6 million for Q4 2025, up 58.96% year-over-year from $20.5 million in Q4 2024, and up 10.72% quarter-over-quarter from $29.4 million in Q3 2025.
Celularity (CELUW) Accumulated Expenses (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of Accumulated Expenses data on file, last reported at $32.6 million in Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $32.6 million, up 58.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $32.6 million (up 58.96% YoY), and the FY2025 annual result was $32.6 million, up 58.96% from the prior year.
- Accumulated Expenses improved to $32.6 million in Q4 2025 per CELUW's latest filing, from $29.4 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $33.4 million in Q2 2025 and troughed at $7.6 million in Q4 2023.
- A 5-year average of $16.8 million and a median of $14.0 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2025: Accumulated Expenses plunged 54.1% in 2023, then jumped 221.35% in 2025.
- A 5-year view of Accumulated Expenses shows it stood at $11.7 million in 2021, then slipped by 22.23% to $9.1 million in 2022, then retreated by 16.42% to $7.6 million in 2023, then jumped by 170.34% to $20.5 million in 2024, then soared by 58.96% to $32.6 million in 2025.
- Business Quant data shows CELUW's Accumulated Expenses at $32.6 million in Q4 2025, $29.4 million in Q3 2025, and $33.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.57 Mn |
| Sep 30, 2025 | 29.42 Mn |
| Jun 30, 2025 | 33.37 Mn |
| Mar 31, 2025 | 25.25 Mn |
| Dec 31, 2024 | 20.49 Mn |
| Sep 30, 2024 | 14.47 Mn |
| Jun 30, 2024 | 10.38 Mn |
| Mar 31, 2024 | 8.76 Mn |
| Dec 31, 2023 | 7.58 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | 9.40 Mn |
| Mar 31, 2023 | 9.56 Mn |
| Dec 31, 2022 | 9.07 Mn |
| Sep 30, 2022 | 18.51 Mn |
| Jun 30, 2022 | 20.48 Mn |
| Mar 31, 2022 | 13.44 Mn |
| Dec 31, 2021 | 11.66 Mn |
| Sep 30, 2021 | 17.10 Mn |
| Dec 31, 2020 | 13.45 Mn |